Various molecular and biological differences have been reported between colon and rectal cancers [28], and SMAD4 may play a more prominent role in the development of colon cancer in EoCRC, potentially through dysregulation of the TGF-β/SMAD4 signaling pathway. This evidence concerns the gene SMAD4 and rectal cancer.